Clinical Trial

The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 28, 2022 (before its estimated May 22, 2026 completion). Its status may not reflect the trial's current state.
Summary
To study the safety and efficacy of intranasal administration of exosomes derived from mesenchymal stromal cells on long-term neurodevelopmental outcome in extremely low birth weight infants born at gestational age 25/0-27/6 weeks.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-08-03.
Trial Details
NCT Number NCT05490173
Lead Sponsor Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
Conditions Premature Birth, Extreme Prematurity, Preterm Intraventricular Hemorrhage, Hypoxia-Ischemia, Cerebral, Neurodevelopmental Disorders
Enrollment 10 participants
Start Date 2022-10-05
Primary Completion 2026-05-22 (estimated)
Study Completion 2026-12-28 (estimated)
Updated on ClinicalTrials.gov 2022-09-28